Ashland Inc. Sells Nutraceuticals Division to Turnspire Capital
WILMINGTON, DE — Ashland Inc. (NYSE: ASH), a global specialty chemicals company, has reached an agreement to divest its nutraceuticals business to private equity firm Turnspire Capital Partners LLC. The …
Ashland Inc. Sells Nutraceuticals Division to Turnspire Capital Read More